20077 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles; Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Pharmaceutical Formulation with Improved Solubility and Bioavailability
#302PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE
#303Nilotinib Compositions with Enhanced Solubility
#304Pharmaceutical compositions comprising a thyroid hormone beta agonist, method of use and method making thereof
#305METHODS AND COMPOSITIONS FOR LOCALIZED AGENT DELIVERY
#306Compositions and Methods for Treating Ocular Diseases
#307DARUNAVIR FORMULATIONS
#308RAPID SET GEL CONCENTRATE FOR MEDICAL PRODUCTS
#309Device and method for improving retention of a therapy in the bladder
#310NANOPARTICLES WITH ENHANCED MUCOSAL PENETRATION OR DECREASED INFLAMMATION
#311In situ gelifying powder
#312AGENTS FOR ORAL COMPOSITION
#313Chemoembolization agents
#314Biodegradable polymer formulations for extended efficacy of botulinum toxin
#315Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil
#316Vitamin and carotenoid powder and its preparation method and application
#317Use of water-soluble realgar solid dispersion in preparation of erythroid differentiation inducer for bone marrow hematopoietic stem cells and/or bone marrow hematopoietic progenitor cells
#318BEADED NONWOVEN MEMBRANE AS A DRUG DELIVERY SYSTEM
#319Polymer compositions for storage and release of polypeptides
#320Methods for preparing stabilized amorphous drug formulations using acoustic fusion
#321Silver Palladium and Silver Platinum Nanoparticles Useful as Antimicrobial and Anticancer Agents
#322ORAL DOSAGE FORMS OF METHYL HYDROGEN FUMARATE AND PRODRUGS THEREOF
#323Nanoparticle comprising a bio-resorbable polyester, a hydrophilic polymer and an acylated human lactoferrin-derived peptide
#324INJECTABLE NEUROSTEROID FORMULATIONS CONTAINING NANOPARTICLES
#325ANTIBIOTIC FORMULATIONS FOR LOWER BACK PAIN
#326Methods for Formulating an API, Composite Materials, and Solid Unit Dosage Forms
#327Compositions comprising molecularly separated cannabinoids and terpene blends and methods of producing
#328IMPLANTS FOR RELEASE OF LIPOPHILIC OR AMPHIPHILIC PHARMACEUTICAL SUBSTANCES
#329NANOPARTICULATE MELOXICAM FORMULATIONS
#330PHARMACEUTICAL COMPOSITION COMPRISING A POTENT INHIBITOR OF URAT1
#331Sericin protein particle with oxidative stress property, method for preparing the same and use thereof
#332Delivery of drug nanoparticles and methods of use thereof
#333NEW CANNABIS TABLET FORMULATIONS AND COMPOSITIONS AND METHODS OF MAKING THE SAME
#334PREPARATION AND APPLICATION OF SURFACE DOUBLE MODIFIED HUMAN SERUM ALBUMIN AS TARGETING NANO DRUG CARRIER
#335Placental tissue component compositions for treatment of skin defects and methods using same
#336Gold Particle for Use in Therapy to Prevent Scar Formation
#337PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL 2 FAMILY INHIBITOR
#338Methods of treating hepatitis delta virus infection
#339PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANT
#340Tablet formulation for CGRP active compounds
#341Pharmaceutical formulation
#342USE OF HYDROGEL COMPOSITION FOR ALLEVIATING DEGENERATIVE JOINT AND TENDON TEAR
#343PHARMACEUTICAL COMPOSITION CONTAINING CROSSLINKED ION EXCHANGE RESIN
#344NUTRITIONAL SUPPLEMENT FOR IMPROVING SEXUAL HEALTH IN MEN AND WOMEN
#345Method for administration
#346Wound treatment containing collagen and a gelatin-reducing agent, and method for promoting wound healing
#347Methods For Producing Chemoembolic Agents For The Delivery Of Anti-Cancer Agents
#348COMPOSITIONS AND METHODS OF TREATING THERAPY RESISTANT CANCER AND USES THEREOF
#349METHODS AND DEVICES FOR TREATING A RETINAL DETACHMENT
#350ADJUVANT SYSTEM FOR ORAL VACCINE ADMINISTRATION
#351Drug-loaded biodegradable microbead compositions including drug-containing vesicular agents
#352ALTERING INFLAMMATORY STATES OF IMMUNE CELLS IN VIVO BY MODULATING CELLULAR ACTIVATION STATES
#353Sustained release olanzapine formulations
#354Methods for reducing bioavailability and absorption of ingested substances
#355NANOPARTICLE COMPOSITIONS AND METHODS OF USE OF PARP INHIBITOR FOR TREATMENT OF CANCER
#356Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor
#357Intravaginal formulation
#358Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse
#359Alternating and semi-alternating poly(ester-anhydride) copolymers
#360NOVEL FORMULATION OF MELOXICAM
#361Pharmaceutical formulation of palbociclib and a preparation method thereof
#362NANOPARTICLE ISOFLAVONE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
#363EFFLUX INHIBITOR COMPOSITIONS AND METHODS OF TREATMENT USING THE SAME
#364DRUG COMPOSITIONS CONTAINING POROUS CARRIERS MADE BY THERMAL OR FUSION-BASED PROCESSES
#365FORMULATIONS OF RIFAXIMIN AND USES THEREOF
#366Pharmaceutical compositions of therapeutically active compounds
#367Pharmaceutical compositions
#368Synergistic Enhancement of the Delivery of Nucleic Acids via Blended Formulations
#369Method for the Production of Commercial Nanoparticle and Microparticle Powders
#370AMORPHOUS ONAPRISTONE COMPOSITIONS AND METHODS OF MAKING THE SAME
#371Treatment of hepatitis delta virus infection
#372Method for improving the dissolution profile of a biologically active material
#373POLY(ESTER UREA)S FOR SHAPE MEMORY AND DRUG DELIVERY
#374Bottlebrush copolymers and uses thereof
#375OIL-IN-WATER METHOD FOR MAKING POLYMERIC IMPLANTS CONTAINING A HYPOTENSIVE LIPID
#376Dry powder compositions of treprostinil prodrugs and methods of use thereof
#377PHARMACEUTICAL COMPOSITION
#378Combination formulation of three antiviral compounds
#379Therapeutic compounds and uses thereof
#380Gelling multiparticulates
#381Production of encapsulated nanoparticles at high volume fractions
#382Novel formulation of metaxalone
#383Nutritive polypeptides and formulations thereof, and methods of production and use thereof
#384Dosage form compositions comprising an inhibitor of Bruton's tyrosine kinase
#385Urea derivatives and uses thereof
#386Nanovectors and uses
#387Application of totarol and pharmaceutical composition containing totarol
#388METHOD FOR INCREASING BIOAVAILABILITY OF NATURAL BIOACTIVE MOLECULES USING BIO-POLYMER COMPLEXATION TECHNOLOGY
#389Solid Pharmaceutical Compositions for Treating HCV
#390Programmable liquid, gel and biohybrid compartments and methods of use
#391IMMUNE-MODIFYING NANOPARTICLES FOR THE TREATMENT OF INFLAMMATORY DISEASES
#392IMMUNE-MODIFYING NANOPARTICLES FOR THE TREATMENT OF INFLAMMATORY DISEASES
#393Compositions and methods for the treatment and prophylaxis of surgical site infections
#394Extended release microparticles comprising drug, and preparation method therefor
#395CONTROLLED RELEASE SYSTEM FOR PULMONARY DELIVERY OF SURFACTANT PROTEIN D
#396Thermo-kinetic mixing for pharmaceutical applications
#397PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS
#398Processes for the preparation of uracil derivatives
#399Processing method for biopolymers using solvent combinations
#400ANIONIC-CORE COMPOSITION FOR DELIVERY OF THERAPEUTIC AGENTS, AND METHODS OF MAKING AND USING THE SAME
#401Hot melt extrusion composition using direct compressible excipient as plasticizer
#402Solid pharmaceutical compositions for treating HCV
#403Methods of fabrication of concentrated and homogeneously wetted massive polymers and applications thereof
#404Electrospraying formation of particles including agents
#405Non-viral gene delivery agent comprising lipopeptide (LP) compounds
#406Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
#407KIDNEY-TARGETING DRUG DELIVERY CARRIER
#408SELECTIVE RELEASE SYSTEM FOR TUMOR THERAPEUTIC AGENTS AND TUMOR DIAGNOSTIC AGENTS AND BIOSENSOR FOR TUMOR TISSUE
#409Ophthalmic drug sustained release formulation and uses thereof
#410Crystalline forms of therapeutic compounds and uses thereof
#411Ophthalmic suspension composition
#412Apparatus for a mass production of monodisperse biodegradeable polymer-based microspheres and a multi-channel forming device incorporatable therein
#413Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
#414Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof
#415Controlled release dosage form
#416Method of delivering an anesthetic agent and glucocorticoid micro and nano bioerodible particles
#417TESTOSTERONE UNDECANOATE COMPOSITIONS
#418DIETARY SUPPLEMENT DERIVED FROM NATURAL PRODUCTS BY HOT MELT EXTRUSION (HME) PROCESSING
#419INTRANASAL DHE FOR THE TREATMENT OF HEADACHE
#420PHARMACEUTICAL COMPOSITION
#421Pharmaceutical compositions containing doravirine, tenofovir disoproxil fumarate and lamivudine
#422Implantable therapeutic delivery system having a nanofibrous core
#423PHARMACEUTICAL DOSAGE FORMS COMPRISING POLY(EPSILON-CAPROLACTONE) AND POLYETHYLENE OXIDE
#424Drug loaded nanoresin particles
#425COMPOSITIONS COMPRISING A CANNABINOID OR A CANNABIS-DERIVED COMPOUND, METHODS OF MAKING AND USE
#426Stealth nanoparticles
#427Nanoparticulate Meloxicam Formulations
#428Stable Bioactive Substances and Methods of Making
#429Gastric residence systems with release rate-modulating films
#430Compositions comprising an urolithin compound
#431Polymer particles
#432Controlled release dosage form with enhanced pharmacokinetics
#433Method for administration
#434PHARMACEUTICAL COMPOSITIONS FOR TREATING ACNE
#435Amorphous dispersion of 4-methyl-3-quinolin-3-ylethynyl-benzoic acid n'-(2-chloro-6-methyl-benzoyl) hydrazide
#436PHARMACEUTICAL COMPOSITION CONTAINING CELECOXIB
#437SOLID COMPOSITIONS OF TRIGLYCERIDES AND USES THEREOF
#438Delivery of drug nanoparticles and methods of use thereof
#439Microparticles and nanoparticles having negative surface charges
#440Therapeutic compounds and uses thereof
#441PALBOCICLIB COMPOSITIONS AND METHODS THEREOF
#442COMPOSITIONS AND DEVICES TO ADMINISTER PHARMACEUTICAL COMPOSITIONS NASALLY
#443LAMOTRIGINE SUSPENSION DOSAGE FORM
#444Nano-crystallized herbal ingredient-containing package and method of preparing herbal decoction
#445METHODS OF TREATING CANCER
#446Compositions of gallium (III) complexes for oral administration
#447PROCESSES FOR MAKING CYCLIC LIPID IMPLANTS FOR INTRAOCULAR USE
#448Localized immunosuppression of allografts for peripheral nerve repair
#449Quinolinone lysyl oxidase-like 2 inhibitors and uses thereof
#450PHARMACEUTICAL COMBINATION COMPOSITION COMPRISING COMPLEX FORMULATIONS OF IVACAFTOR AND LUMACAFTOR AND THEIR SALTS AND DERIVATIVES, PROCESS FOR THEIR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
#451COMPOSITION AND METHOD FOR THE TOPICAL TREATMENT OF SEVERE ACNE
#452CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS
#453Pharmaceutical Compositions For Poorly Water-Soluble Compounds
#454Nanoparticles for controlled release of Sorafenib and Sorafenib derivatives
#455COMPLEXES OF LUMACAFTOR AND ITS SALTS AND DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
#456Solid Composition Comprising Amorphous Sofosbuvir
#457Nanoparticulate meloxicam formulations
#458Pharmaceutical formulation of palbociclib and a preparation method thereof
#459Pharmaceutical formulation of palbociclib and a preparation method thereof
#460Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity
#461Sustained release particle formulations
#462RAPIDLY DISINTEGRATING FORMULATIONS AND METHODS OF USE
#463Placental tissue component compositions for treatment of skin defects and methods using same
#464Oral rapamycin nanoparticle preparations and use
#465Crystalline Maltitol Powder Less Prone to Consolidation and Method for Production Thereof
#466Method Of Manufacturing Fine Particles Suitable For Orally Disintegrating Pharmaceutical Dosage Forms
#467Methods for treating cryptosporidiosis using triazolopyridazines
#468ANTIBIOTIC FORMULATIONS FOR LOWER BACK PAIN
#469Pharmaceutical compositions of therapeutically active compounds
#470Telodendrimers with riboflavin moieties and nanocarriers and methods of making and using same
#471METHOD FOR ADMINISTRATION
#472DRUG-POLYMER PARTICLES WITH SUSTAINED RELEASE PROPERTIES
#473CYCLODEXTRIN COMPOSITIONS ENCAPSULATING A SELECTIVE ATP INHIBITOR AND USES THEREOF
#474Complexes of Celecoxib and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them
#475Pharmaceutical composition and use
#476Urea derivatives and uses thereof
#477Nasal powder formulation for treatment of hypoglycemia
#478NOVEL FORMULATIONS OF A BRUTON'S TYROSINE KINASE INHIBITOR
#479SOLID DISPERSIONS CONTAINING AN APOPTOSIS-INDUCING AGENT
#480Intranasal DHE for the Treatment of Headache
#481Pharmaceutical composition and administrations thereof
#482PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL 2 FAMILY INHIBITOR
#483Geometric configurations for gastric residence systems
#484Pharmaceutical formulation comprising cineole and amoxicillin
#485Controlled release dosage form
#486Pharmaceutical compositions containing doravirine, tenofovir disoproxil fumarate and lamivudine
#487PHARMACEUTICAL COMPOSITIONS
#488Hemostatic material and spray
#489Pharmaceutical compositions with enhanced stability
#490PHARMACEUTICAL FORMULATIONS
#491Medicinal composition for inhalation
#492Prebiotic formulation
#493Compositions and methods for nanoparticle lyophile forms
#494Stable Pharmaceutical Composition of Vortioxetine Hydrobromide
#495Solid Pharmaceutical Compositions for Treating HCV
#496Synergistic enhancement of the delivery of nucleic acids via blended formulations
#497Therapeutic compounds and uses thereof
#498PEDIATRIC FORMULATION
#499Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
#500Composition comprising an organic liquid diluent and a cellulose ether of very low viscosity
#501Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-l,2-dithiole-3-thione, taste-modified formulations, and methods of making and using same
#502Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione, and methods of making and using same
#503TABLET FORMULATION FOR CGRP ACTIVE COMPOUNDS
#504Anticancer compositions
#505NANOPARTICLES FOR DERMAL AND SYSTEMIC DELIVERY OF DRUGS
#506SUSTAINED-RELEASE COMPOSITION, METHOD FOR FABRICATING, AND USE THEREOF
#507FORMULATIONS OF VILOXAZINE
#508Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
#509PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE
#510Odor masking formulations for natural compounds
#511OIL-IN-WATER METHOD FOR MAKING POLYMERIC IMPLANTS CONTAINING A HYPOTENSIVE LIPID
#512POWDER FORM AND USE OF HYDROGEL COMPOSITIONS FOR ALLEVIATING DEGENERATIVE JOINT AND TENDON TEAR
#513Complexes of ivacaftor and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them
#514DOSAGE FORM COMPOSITIONS COMPRISING AN INHIBITOR OF BRUTON'S TYROSINE KINASE
#515Solid Pharmaceutical Composition Comprising Amorphous Sofosbuvir
#516Nutritional supplement for improving sexual health in men and women
#517Treatment of hepatitis delta virus infection
#518Formulations of deferasirox and methods of making the same
#519EFFLUX INHIBITOR COMPOSITIONS AND METHODS OF TREATMENT USING THE SAME
#520COMBINATION THERAPY METHODS FOR TREATING PROLIFERATIVE DISEASES
#521Controlled release dosage form
#522Nanoparticle isoflavone compositions and methods of making and using the same
#523PROCESSES FOR PRODUCING COMPOSITIONS WITH IMPROVED SAFETY PROFILE HAVING LIPASE ACTIVITY AND COMPOSITIONS SUITABLE FOR PHARMACEUTICAL USE
#524Pharmaceutical composition containing celecoxib
#525TAMPER-RESISTANT DOSAGE FORM CONTAINING ONE OR MORE PARTICLES
#526Use of an amino sugar as plasticizer
#527Formulations of a compound modulating kinases
#528Encapsulation-free controlled protein release system
#529Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
#530Injectable composition for delivery of a biologically active agent
#531COMPOSITIONS BASED ON PLANT EXTRACTS FOR INHIBITION OF THE 5-ALPHA REDUCTASE
#532Method of treatment using nanoparticulate ganaxolone formulations
#533GANAXOLONE FORMULATION AND USE THEREOF
#534Solid oral formulation of fenretinide
#535COMPOSITION AND METHOD OF PREPARATION OF RISPERIDONE EXTENDED RELEASE PREPARATION
#536Particle size and distribution of polymer for melt extrusion application
#537Polyelectrolyte complexes for delivery of agents to the CNS
#538MODIFIED RELEASE ABUSE DETERRENT DOSAGE FORMS
#539Process for preparing shaped articles for administration to animals
#540ADJUVANT SYSTEM FOR ORAL VACCINE ADMINISTRATION
#541SYSTEM AND APPLIANCE FOR EXTENDING THE PRODUCTION OF NITRIC OXIDE BY SPINACH EXTRACT MICROENCAPSULATED POWDER AND ACIDIC GEL
#542Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil
#543Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil
#544Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil
#545Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil
#546Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil
#547Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil
#548Amine cationic lipids and uses thereof
#549Transdermal device including porous microparticles
#550Orally Disintegrating Tablet Formulation For Enhanced Bioavailability
#551Snuff composition
#552Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil
#553Crystalline forms of therapeutic compounds and uses thereof
#554Nanospheres of SEC14-like proteins and cognate ligands
#555FORMULATION OF TICAGRELOR OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
#556Controlled release dosage form with enhanced pharmacokinetics
#557Compositions comprising an urolithin compound
#558BRIDGED POLYETHYLENE GLYCOL-ALIPHATIC POLYESTER BLOCK COPOLYMER, PREPARATION METHOD FOR SAME, INTERMEDIATE OF SAME, AND USES THEREOF
#559Immune-modifying nanoparticles for the treatment of inflammatory diseases
#560Nanoparticles of indirubin, derivatives thereof and methods of making and using same
#561Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse
#562Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse
#563Small molecule agents, compositions, and formulations, for internal use, displaying inhibitory activity against gram-positive and/or gram-negative organisms
#564Temperature-sensitive composite and method for preparing same
#565Rapid release pharmaceutical formulations containing algal cellulose
#566NUCLEIC ACID-CONTAINING LIPID PARTICLES AND RELATED METHODS
#567Polymer particles
#568PHARMACEUTICAL COMPOSITION
#569Afatinib-containing formulation
#570Therapeutic Nanoparticles Having EGFR Ligands and Methods of Making and Using Same
#571High drug loading pharmaceutical compositions
#572Pharmaceutical compositions comprising phenylaminopyrimidine derivative
#573Composition for inhibiting angiogenesis comprising nanoparticle-vitreous body-based protein complex as active ingredient, and use thereof
#574HEPATOPROTECTIVE PARTICLES AND SYSTEMS AND METHODS OF USE THEREOF
#575MAGNETIC FIELD SENSITIVE NANO COMPLEX AND METHOD FOR MANUFACTURING THE SAME
#576DRUG LOADED NANORESIN PARTICLES
#577Method for treating an autoimmune neurological disease and/or neurodegenerative disease and pharmaceutical formulations for a liquid dosage form and a controlled release dosage form
#578Self-film-forming composition for oral care
#579PHARMACEUTICAL COMPOSITION
#580Polyacetal polymers, conjugates, particles and uses thereof
#581Compositions and methods for stabilization of active agents
#582Thermo-kinetic mixing for pharmaceutical applications
#583METHODS AND COMPOSITIONS FOR DELIVERY OF MEDICAMENTS TO THE LUNGS
#584Methods for producing chemoembolic agents for the delivery of anti-cancer agents
#585PRODUCT COMPRISING HYDROLIZED COLLAGEN AND AT LEAST ONE AMORPHOUS MICRONIZED DRUG, PROCESS FOR THE PREPARATION THEREOF AND RELATED USES IN MEDICAL FIELD
#586Processes for the preparation of SGLT-2 inhibitors, intermediates thereof
#587Processes for the preparation of uracil derivatives
#588Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials
#589Sustained-release composition, method for fabricating, and use thereof
#590Nucleic acid nanostructures with core motifs
#591Urea derivatives and uses thereof
#592Urea derivatives and uses thereof
#593Vaccine compositions
#594Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections
#595Pharmaceutical compositions of therapeutically active compounds
#596Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions
#597BIOCOMPATIBLE WATER-SOLUBLE POLYMERS INCLUDING SULFOXIDE FUNCTIONALITY
#598TREATING FUNGAL INFECTION OF THE NAIL UNIT
#599Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
#600METHOD OF MAKING DIALKYL SULFOSUCCINATE COMPOSITIONS